Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias

First of its kind, all-in-one Sphere-9™ Catheter with pulsed field ablation, radiofrequency, and high density mapping integrated with intuitive mapping and navigation platform DUBLIN, March 15, 2023 -- (Healthcare Sales & Marketing Network) -- Medtroni... Devices, Interventional, Cardiology, Regulatory Medtronic, Affera , Affera Prism-1, cardiac mapping, Sphere-9
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news